UCLA Health: Immunotherapy Helps Extend the Lives of Patients With Rare Form of Skin Cancer
August 15, 2025
August 15, 2025
LOS ANGELES, California, Aug. 15 (TNSjou) -- The UCLA Health issued the following news release:
* * *
Immunotherapy helps extend the lives of patients with rare form of skin cancer
Study found pembrolizumab shrank or eliminated tumors in nearly 90% of participants with desmoplastic melanoma that cannot be surgically removed
*
A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps . . .
* * *
Immunotherapy helps extend the lives of patients with rare form of skin cancer
Study found pembrolizumab shrank or eliminated tumors in nearly 90% of participants with desmoplastic melanoma that cannot be surgically removed
*
A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps . . .